152 related articles for article (PubMed ID: 15716482)
1. Development of a physiologically based pharmacokinetic model for ethylene glycol and its metabolite, glycolic Acid, in rats and humans.
Corley RA; Bartels MJ; Carney EW; Weitz KK; Soelberg JJ; Gies RA; Thrall KD
Toxicol Sci; 2005 May; 85(1):476-90. PubMed ID: 15716482
[TBL] [Abstract][Full Text] [Related]
2. Extension of a PBPK model for ethylene glycol and glycolic acid to include the competitive formation and clearance of metabolites associated with kidney toxicity in rats and humans.
Corley RA; Saghir SA; Bartels MJ; Hansen SC; Creim J; McMartin KE; Snellings WM
Toxicol Appl Pharmacol; 2011 Feb; 250(3):229-44. PubMed ID: 21074520
[TBL] [Abstract][Full Text] [Related]
3. Dose-dependent nonlinear pharmacokinetics of ethylene glycol metabolites in pregnant (GD 10) and nonpregnant Sprague-Dawley rats following oral administration of ethylene glycol.
Pottenger LH; Carney EW; Bartels MJ
Toxicol Sci; 2001 Jul; 62(1):10-9. PubMed ID: 11399788
[TBL] [Abstract][Full Text] [Related]
4. The impact of dose rate on ethylene glycol developmental toxicity and pharmacokinetics in pregnant CD rats.
Carney EW; Tornesi B; Liberacki AB; Markham DA; Weitz KK; Luders TM; Studniski KG; Blessing JC; Gies RA; Corley RA
Toxicol Sci; 2011 Jan; 119(1):178-88. PubMed ID: 20952502
[TBL] [Abstract][Full Text] [Related]
5. Incorporation of therapeutic interventions in physiologically based pharmacokinetic modeling of human clinical case reports of accidental or intentional overdosing with ethylene glycol.
Corley RA; McMartin KE
Toxicol Sci; 2005 May; 85(1):491-501. PubMed ID: 15716481
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the metabolism of ethylene glycol and glycolic acid in vitro by precision-cut tissue slices from female rat, rabbit and human liver.
Booth ED; Dofferhoff O; Boogaard PJ; Watson WP
Xenobiotica; 2004 Jan; 34(1):31-48. PubMed ID: 14742135
[TBL] [Abstract][Full Text] [Related]
7. Ethylene Glycol and Metabolite Concentrations in Fatal Ethylene Glycol Poisonings.
Viinamäki J; Sajantila A; Ojanperä I
J Anal Toxicol; 2015; 39(6):481-5. PubMed ID: 25907169
[TBL] [Abstract][Full Text] [Related]
8. Human inhalation exposure to ethylene glycol.
Carstens J; Csanády GA; Faller TH; Filser JG
Arch Toxicol; 2003 Aug; 77(8):425-32. PubMed ID: 12856104
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of ethylene glycol. II. Tissue distribution, dose-dependent elimination, and identification of urinary metabolites following single intravenous, peroral or percutaneous doses in female Sprague-Dawley rats and CD-1 mice.
Frantz SW; Beskitt JL; Grosse CM; Tallant MJ; Dietz FK; Ballantyne B
Xenobiotica; 1996 Nov; 26(11):1195-220. PubMed ID: 8948094
[TBL] [Abstract][Full Text] [Related]
10. Ethylene glycol developmental toxicity: unraveling the roles of glycolic acid and metabolic acidosis.
Carney EW; Freshour NL; Dittenber DA; Dryzga MD
Toxicol Sci; 1999 Jul; 50(1):117-26. PubMed ID: 10445760
[TBL] [Abstract][Full Text] [Related]
11. A toxicological review of the ethylene glycol series: Commonalities and differences in toxicity and modes of action.
Fowles J; Banton M; Klapacz J; Shen H
Toxicol Lett; 2017 Aug; 278():66-83. PubMed ID: 28689762
[TBL] [Abstract][Full Text] [Related]
12. Identification of proximate toxicant for ethylene glycol developmental toxicity using rat whole embryo culture.
Carney EW; Liberacki AB; Bartels MJ; Breslin WJ
Teratology; 1996 Jan; 53(1):38-46. PubMed ID: 8928086
[TBL] [Abstract][Full Text] [Related]
13. Ethylene glycol and glycolate kinetics in rats and dogs.
Hewlett TP; Jacobsen D; Collins TD; McMartin KE
Vet Hum Toxicol; 1989 Apr; 31(2):116-20. PubMed ID: 2929116
[TBL] [Abstract][Full Text] [Related]
14. Physiologically based pharmacokinetics of 2-butoxyethanol and its major metabolite, 2-butoxyacetic acid, in rats and humans.
Corley RA; Bormett GA; Ghanayem BI
Toxicol Appl Pharmacol; 1994 Nov; 129(1):61-79. PubMed ID: 7974497
[TBL] [Abstract][Full Text] [Related]
15. Physiologically based pharmacokinetics and the dermal absorption of 2-butoxyethanol vapor by humans.
Corley RA; Markham DA; Banks C; Delorme P; Masterman A; Houle JM
Fundam Appl Toxicol; 1997 Oct; 39(2):120-30. PubMed ID: 9344624
[TBL] [Abstract][Full Text] [Related]
16. Inhalation and epidermal exposure of volunteers to ethylene glycol: kinetics of absorption, urinary excretion, and metabolism to glycolate and oxalate.
Upadhyay S; Carstens J; Klein D; Faller TH; Halbach S; Kirchinger W; Kessler W; Csanády GA; Filser JG
Toxicol Lett; 2008 May; 178(2):131-41. PubMed ID: 18430528
[TBL] [Abstract][Full Text] [Related]
17. Ethylene glycol: an estimate of tolerable levels of exposure based on a review of animal and human data.
Hess R; Bartels MJ; Pottenger LH
Arch Toxicol; 2004 Dec; 78(12):671-80. PubMed ID: 15372138
[TBL] [Abstract][Full Text] [Related]
18. Species-specificity of ethylene glycol-induced developmental toxicity: toxicokinetic and whole embryo culture studies in the rabbit.
Carney EW; Tornesi B; Markham DA; Rasoulpour RJ; Moore N
Birth Defects Res B Dev Reprod Toxicol; 2008 Dec; 83(6):573-81. PubMed ID: 19025792
[TBL] [Abstract][Full Text] [Related]
19. Use of in vitro data in developing a physiologically based pharmacokinetic model: Carbaryl as a case study.
Yoon M; Kedderis GL; Yan GZ; Clewell HJ
Toxicology; 2015 Jun; 332():52-66. PubMed ID: 24863738
[TBL] [Abstract][Full Text] [Related]
20. Development of a physiologically-based pharmacokinetic model of 2-phenoxyethanol and its metabolite phenoxyacetic acid in rats and humans to address toxicokinetic uncertainty in risk assessment.
Troutman JA; Rick DL; Stuard SB; Fisher J; Bartels MJ
Regul Toxicol Pharmacol; 2015 Nov; 73(2):530-43. PubMed ID: 26188115
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
